Clinical Trials Logo

Diabetic Macular Edema clinical trials

View clinical trials related to Diabetic Macular Edema.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05607810 Enrolling by invitation - Clinical trials for Diabetic Retinopathy

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Start date: August 10, 2022
Phase:
Study type: Observational

This is a prospective, observational study designed to evaluate the long-term safety and tolerability of ADVM-022 in participants with diabetic macular edema (DME). Participants who previously participated in the INFINITY parent study and received a single unilateral intravitreal dose of ADVM-022 are eligible for enrollment upon completion of the end of study visit in the parent study.

NCT ID: NCT03918590 Enrolling by invitation - Clinical trials for Diabetic Macular Edema

Post Intravitreal Injection Topical NSAID vs. Patching

Start date: December 3, 2018
Phase: Phase 4
Study type: Interventional

A prospective randomized trial, to evaluate post-injection comfort measures comparing topical NSAID (nepafenac 0.3% suspension) and patching.

NCT ID: NCT02063321 Enrolling by invitation - Clinical trials for Diabetic Retinopathy

Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak Republic

Start date: December 2012
Phase: N/A
Study type: Observational

The aim of the study is to find out prevalence of diabetic macular edema (DME) in patients with diabetes mellitus in Slovak Republic.The outcome of the project will be epidemiology survey, prevalence of wet form of Diabetic Macular Edema in relation to duration of diabetes, type of diabetes, treatment (insulin vs. OAD or combination) etc. and identification of prognostic factors leading to development of DME.